Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out moreThis comprehensive guide is designed to help you navigate the intricate landscape of family business and private wealth in the Middle East, where family businesses constitute approximately 60% of GDP and employ 80% of the workforce in the GCC, offering unparalleled opportunities for wealth creation and preservation.
Packed with insights, strategies, and expert advice from our talented lawyers, Legacy provides tailored solutions to the unique challenges of asset protection, succession planning, and dispute resolution in this dynamic region.Read the publication and equip yourself with the knowledge and tools necessary to thrive, whether you’re a seasoned investor, a family business owner, part of the next generation, or a newcomer exploring opportunities in the region.
Read NowKuwait’s Ministry of Health (“MOH”) issued Resolution No. 100 of 2023 in April 2023 (“Resolution 100/2023”). Resolution 100/2023 repeals a previous MOH resolution from 2022, which regulated the mechanism for importing non-registered medicines and pharmaceutical products. Further, it adds a new article to Resolution No. 361 of 2019. The new article allows for medicines used in the diagnosis, treatment, or prevention of diseases and registered with international supervisory authorities without any alternative replacements available, to be registered at the request of authorities at the Ministry of Health. This will be done in accordance with the requirements set out by the Department for the Registration and Control of Medical and Plant Based Medicines at the Ministry of Health.
Al Tamimi & Company are able assist in ensuring compliance with the evolving Ministry of Health Resolutions in Kuwait.
To learn more about our services and get the latest legal insights from across the Middle East and North Africa region, click on the link below.